-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2017 to Q4 2024.
- Autolus Therapeutics plc Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $1.46M.
- Autolus Therapeutics plc Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $1.53M.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2024 was $1.53M.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was -$19K, a 107% decline from 2022.
- Autolus Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $272K, a 369% increase from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)